Procedural Discomfort Related to Number of Intradetrusor Botox Injections

Inclusion Criteria: * Women scheduled to undergo 100 units intradetrusor BTX-A injections in the office for the diagnosis of idiopathic overactive bladder within the departments of Urology and Urogynecology * 18 years of age or older * Able to give informed consent in English or Spanish * Understand and are willing to undergo follow-up and complete all questionnaires as described in this protocol Exclusion Criteria: * Neurogenic bladder related to prior diagnosis of neurological conditions such as cerebral vascular accident within 6 months prior to treatment, Parkinson's Disease, Multiple Sclerosis, myelomeningocele, traumatic neurologic or spinal injury, or idiopathic diagnosis of neurogenic bladder. * Symptomatic UTI at the time of procedure, defined as positive nitrites or high-volume leukocyte esterase on urine dip in addition to at least one of the following symptoms: dysuria, gross hematuria, suprapubic pain, frequency/urgency above baseline * Diagnosis of a bladder pain syndrome or other chronic pain syndromes including fibromyalgia, chronic pelvic pain, pelvic floor dysfunction, levator myalgia * Known bladder malignancy * Previous history of bladder augmentation or reconstructive surgery not related to prolapse